+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
ID07301801

Evaluating 68Ga-FL-031 PET Imaging for Diagnosis and Staging of Small Cell Lung Cancer, Breast Cancer, Nasopharyngeal Carcinoma, and Other Tumors

Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-12-24

10

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of 68Ga-FL-031 PET imaging in diagnosing and staging malignant tumors, including small cell lung cancer, breast cancer, nasopharyngeal carcinoma, and others. This study aims to analyze how well 68Ga-FL-031 PET imaging detects tumor lesions, their location, nature, and spread compared to 18F-FDG PET imaging. It also examines the relationship between the uptake of 68Ga-FL-031 in tumor tissue and the expression of the SSTR2 target through immunohistochemical staining. Participants will receive injections of two imaging agents 68Ga-FL-031 and 18F-FDG, followed by PET scans at different times during outpatient or inpatient visits. The study involves collecting clinical data, blood and urine tests, liver and kidney function tests, electrocardiograms, and various imaging results. These data will be compared with biopsy or surgical specimen histopathology to evaluate diagnostic accuracy. During the study, patients will provide general health information and undergo multiple assessments to monitor the uptake values of lesions and biodistribution over one year. Researchers will review pathological sections of tumor tissue within the same period. The study requires participants to follow the prescribed research procedures, including signing informed consent and cooperating fully throughout the process.

CONDITIONS

Brief Title

Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors

Research Team

X

Xiaoli Lan, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here